Cargando…
PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043208/ http://dx.doi.org/10.1186/1546-0096-11-S2-P152 |
| _version_ | 1782318884226859008 |
|---|---|
| author | De Benedetti, F Brunner, HI Baildam, E Burgos-Vargas, R Horneff, G Huppertz, HI Minden, K Myones, BL Onel, K Wang, J Bharucha, K Lovell, D Martini, A Ruperto, N |
| author_facet | De Benedetti, F Brunner, HI Baildam, E Burgos-Vargas, R Horneff, G Huppertz, HI Minden, K Myones, BL Onel, K Wang, J Bharucha, K Lovell, D Martini, A Ruperto, N |
| author_sort | De Benedetti, F |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4043208 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40432082014-06-17 PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA) De Benedetti, F Brunner, HI Baildam, E Burgos-Vargas, R Horneff, G Huppertz, HI Minden, K Myones, BL Onel, K Wang, J Bharucha, K Lovell, D Martini, A Ruperto, N Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4043208/ http://dx.doi.org/10.1186/1546-0096-11-S2-P152 Text en Copyright © 2013 De Benedetti et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation De Benedetti, F Brunner, HI Baildam, E Burgos-Vargas, R Horneff, G Huppertz, HI Minden, K Myones, BL Onel, K Wang, J Bharucha, K Lovell, D Martini, A Ruperto, N PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA) |
| title | PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA) |
| title_full | PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA) |
| title_fullStr | PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA) |
| title_full_unstemmed | PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA) |
| title_short | PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA) |
| title_sort | pres-final-2140: neutropenia with tocilizumab (tcz) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (sjia) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043208/ http://dx.doi.org/10.1186/1546-0096-11-S2-P152 |
| work_keys_str_mv | AT debenedettif presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT brunnerhi presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT baildame presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT burgosvargasr presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT horneffg presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT huppertzhi presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT mindenk presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT myonesbl presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT onelk presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT wangj presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT bharuchak presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT lovelld presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT martinia presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT ruperton presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia AT presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia |